This byline is co-authored by Ramji Vasudevan, Head of Life Sciences at Altimetrik, and Adam Caplan, President of Digital Business and AI at Altimetrik. Together, they bring deep expertise in helping pharmaceutical enterprises bridge the gap between innovation pilots and scalable adoption of digital and AI solutions.
In this article published in PME (Pharmaceutical Market Europe) they explain how pharmaceutical firms are moving beyond cautious pilots to enterprise-scale adoption of digital engineering and AI solutions. From AI-driven supply chain optimization and intelligent manufacturing to patient onboarding, compliance bots, and conversational analytics, Ramji and Adam outline how practical AI applications are already improving efficiency, reducing costs, and enhancing patient outcomes. They also highlight the rise of multi-agent orchestration and data-connected AI systems as the next frontier for regulated pharma environments.
Altimetrik partners with Google Cloud to launch a Gemini Enterprise capability center, enabling production-scale AI agents and accelerating enterprise AI transformation globally.
A landmark HFS Research and Altimetrik study of 505 Global 2000 executives exposes a critical AI governance gap only 14% of enterprises have a clear AI strategy, and most lack defined human accountability when AI makes decisions. Here’s what it means for your organization.
DETROIT — April 8, 2026 — Across enterprises, AI shapes hiring decisions, influences capital allocation, triggers compliance actions, and steers operational trade-offs at a scale no executive team can realistically supervise. A new report from Altimetrik, in partnership with HFS Research, finds that the vast majority of enterprises have deployed AI without answering a fundamental […]
Altimetrik is committed to protecting your personal information. To apply for a position, you will need to provide your email address and create a login. Your information will be used in accordance with applicable data privacy laws, our Privacy Policy, and our Privacy Notice.
